Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Oropharyngeal Microbiome Profiled at Admission is Predictive of the Need for Respiratory Support Among COVID-19 Patients

View ORCID ProfileEvan S Bradley, Abigail L. Zeamer, View ORCID ProfileVanni Bucci, Lindsey Cincotta, Marie-Claire Salive, Protiva Dutta, Shafik Mutaawe, Otuwe Anya, Christopher Tocci, Ann Moormann, Doyle V. Ward, Beth A. McCormick, View ORCID ProfileJohn P Haran
doi: https://doi.org/10.1101/2022.02.28.22271627
Evan S Bradley
1Department of Emergency Medicine, UMass Memorial Medical Center 55 Lake Avenue North, Worcester MA, 01605
2Program in Microbiome Dynamics, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester MA, 01605
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Evan S Bradley
  • For correspondence: evan.bradley@umassmed.edu
Abigail L. Zeamer
2Program in Microbiome Dynamics, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester MA, 01605
3Department of Microbiology and Physiologic Systems, 55 Lake Avenue North, Worcester MA, 01605
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vanni Bucci
2Program in Microbiome Dynamics, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester MA, 01605
3Department of Microbiology and Physiologic Systems, 55 Lake Avenue North, Worcester MA, 01605
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vanni Bucci
Lindsey Cincotta
1Department of Emergency Medicine, UMass Memorial Medical Center 55 Lake Avenue North, Worcester MA, 01605
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-Claire Salive
1Department of Emergency Medicine, UMass Memorial Medical Center 55 Lake Avenue North, Worcester MA, 01605
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Protiva Dutta
1Department of Emergency Medicine, UMass Memorial Medical Center 55 Lake Avenue North, Worcester MA, 01605
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shafik Mutaawe
1Department of Emergency Medicine, UMass Memorial Medical Center 55 Lake Avenue North, Worcester MA, 01605
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Otuwe Anya
1Department of Emergency Medicine, UMass Memorial Medical Center 55 Lake Avenue North, Worcester MA, 01605
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Tocci
4Biology and Biotechnology, Worcester Polytechnique Institute, 100 Institute Road, Worcester, MA 01609
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann Moormann
5Department of Medicine, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Doyle V. Ward
2Program in Microbiome Dynamics, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester MA, 01605
3Department of Microbiology and Physiologic Systems, 55 Lake Avenue North, Worcester MA, 01605
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beth A. McCormick
2Program in Microbiome Dynamics, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester MA, 01605
3Department of Microbiology and Physiologic Systems, 55 Lake Avenue North, Worcester MA, 01605
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John P Haran
1Department of Emergency Medicine, UMass Memorial Medical Center 55 Lake Avenue North, Worcester MA, 01605
2Program in Microbiome Dynamics, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester MA, 01605
3Department of Microbiology and Physiologic Systems, 55 Lake Avenue North, Worcester MA, 01605
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John P Haran
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The clinical course of infection due to respiratory viruses such as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2), the causative agent of Coronavirus Disease 2019 (COVID-19) is thought to be influenced by the community of organisms that colonizes the upper respiratory tract, the oropharyngeal microbiome. In this study, we examined the oropharyngeal microbiome of suspected COVID-19 patients presenting to the Emergency Department and an inpatient COVID-19 unit with symptoms of acute COVID-19. Of 115 enrolled patients, 74 were confirmed COVID-19+ and 50 had symptom duration of 14 days or less; 38 acute COVID-19+ patients (76%) went on to require respiratory support. Although no microbiome features were found to be significantly different between COVID-19+ and COVID-19-patients, when we conducted random forest classification modeling (RFC) to predict the need of respiratory support for the COVID-19+ patients our analysis identified a subset of organisms and metabolic pathways whose relative abundance, when combined with clinical factors (such as age and Body Mass Index), was highly predictive of the need for respiratory support (F1 score 0.857). Microbiome Multivariable Association with Linear Models (MaAsLin2) analysis was then applied to the features identified as predicative of the need for respiratory support by the RFC. This analysis revealed reduced abundance of Prevotella salivae and metabolic pathways associated with lipopolysaccharide and mycolic acid biosynthesis to be the strongest predictors of patients requiring respiratory support. These findings suggest that composition of the oropharyngeal microbiome in COVID-19 may play a role in determining who will suffer from severe disease manifestations.

Importance The microbial community that colonizes the upper airway, the oropharyngeal microbiome, has the potential to affect how patients respond to respiratory viruses such as SARS-CoV2, the causative agent of COVID-19. In this study, we investigated the oropharyngeal microbiome of COVID-19 patients using high throughput DNA sequencing performed on oral swabs. We combined patient characteristics available at intake such as medical comorbidities and age, with measured abundance of bacterial species and metabolic pathways and then trained a machine learning model to determine what features are predicative of patients needing respiratory support in the form of supplemental oxygen or mechanical ventilation. We found that decreased abundance of some bacterial species and increased abundance of pathways associated bacterial products biosynthesis was highly predictive of needing respiratory support. This suggests that the oropharyngeal microbiome affects disease course in COVID-19 and could be targeted for diagnostic purposes to determine who may need oxygen, or therapeutic purposes such as probiotics to prevent severe COVID-19 disease manifestations.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by The Society for Academic Emergency Medicine as well as the Dean of University of Massachusetts Medical School and the many donors who through their financial support made this work possible. We would also like to thank the NIH for funding that provided salary support for this work (1RF1AG067483-01).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Institutional Review Board at the University of Massachusetts Medical School approved this study (protocol # H00020145)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 28, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Oropharyngeal Microbiome Profiled at Admission is Predictive of the Need for Respiratory Support Among COVID-19 Patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Oropharyngeal Microbiome Profiled at Admission is Predictive of the Need for Respiratory Support Among COVID-19 Patients
Evan S Bradley, Abigail L. Zeamer, Vanni Bucci, Lindsey Cincotta, Marie-Claire Salive, Protiva Dutta, Shafik Mutaawe, Otuwe Anya, Christopher Tocci, Ann Moormann, Doyle V. Ward, Beth A. McCormick, John P Haran
medRxiv 2022.02.28.22271627; doi: https://doi.org/10.1101/2022.02.28.22271627
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Oropharyngeal Microbiome Profiled at Admission is Predictive of the Need for Respiratory Support Among COVID-19 Patients
Evan S Bradley, Abigail L. Zeamer, Vanni Bucci, Lindsey Cincotta, Marie-Claire Salive, Protiva Dutta, Shafik Mutaawe, Otuwe Anya, Christopher Tocci, Ann Moormann, Doyle V. Ward, Beth A. McCormick, John P Haran
medRxiv 2022.02.28.22271627; doi: https://doi.org/10.1101/2022.02.28.22271627

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (431)
  • Anesthesia (99)
  • Cardiovascular Medicine (942)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (418)
  • Epidemiology (8969)
  • Forensic Medicine (4)
  • Gastroenterology (418)
  • Genetic and Genomic Medicine (1938)
  • Geriatric Medicine (190)
  • Health Economics (400)
  • Health Informatics (1322)
  • Health Policy (657)
  • Health Systems and Quality Improvement (517)
  • Hematology (211)
  • HIV/AIDS (416)
  • Infectious Diseases (except HIV/AIDS) (10769)
  • Intensive Care and Critical Care Medicine (570)
  • Medical Education (199)
  • Medical Ethics (52)
  • Nephrology (221)
  • Neurology (1818)
  • Nursing (108)
  • Nutrition (271)
  • Obstetrics and Gynecology (351)
  • Occupational and Environmental Health (469)
  • Oncology (992)
  • Ophthalmology (296)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (576)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1891)
  • Public and Global Health (4109)
  • Radiology and Imaging (674)
  • Rehabilitation Medicine and Physical Therapy (363)
  • Respiratory Medicine (547)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (206)
  • Toxicology (38)
  • Transplantation (109)
  • Urology (80)